Linkoeping University Clinical Trials
Sponsors / Linkoeping University
Linkoeping University appears as lead sponsor on 218 trial records in ClinicalTrials.gov. Of these, 31 are recruiting, 13 are active without new recruitment, and 120 have completed. The registry records 8 terminated or withdrawn trials for Linkoeping University. The most common reasons cited for termination include slow or insufficient recruitment, efficacy or futility findings. Planned participant enrollment across these trials sums to 2,467,523. Figures on this page are sourced from ClinicalTrials.gov and refreshed with each registry update.
218
Total Trials
31
Recruiting
13
Other Active
120
Completed
8
Terminated / Withdrawn
2,467,523
Total Enrollment
Termination reasons: Recruitment63% · Other25% · Efficacy13%
Recent Terminations
- Type 2 Diabetes"Interim analysis of primary outcome (HbA1c at 6 months) revealed no numerical differences after 80 included participants. Further inclusion of participants to reach prespecified N to evaluate primary outcome deemed futile. 138 participants "
- NCT04147000 Stopped Nov 2023Anxiety Disorders"Problem with recruiting as a consequence of COVID-19"
- Family Health"We have closed the study because of slow inclusion of families"
- Communication"To difficult to recruit."
- Major Depressive Disorder"Too slow recruiting of patients/therapists to the study"
- Aortic Valve Stenosis"Slow inclusion rate, failure to recruit a priori determined no of patients."
- Mild - Major Depression"We have recruited and treated 79 participants"
- Hot Flashes"Unacceptable high drop-out rate."
Active Trials (13 total)
- NCT07389161
- NCT07499024
- NCT07534930
- NCT05641662
- NCT07275931
- NCT06277232
- Acute Pain PHASE2NCT07409753
- NCT07391540
- NCT06290336
- NCT05782582
- NCT06907134
- NCT05977218
- Diabetes NANCT06862128
- NCT05935722
- NCT06406972
- NCT06424509
- NCT05808712
- NCT04815889
- NCT06136494
- Adherence NANCT06748443